Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer
Status:
Terminated
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well tanespimycin works in treating women with refractory
locally advanced or metastatic breast cancer. Drugs used in chemotherapy, such as
tanespimycin, work in different ways to stop tumor cells from dividing so they stop growing
or die